{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:03:12Z","timestamp":1793847792028,"version":"4.6.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2023ZD0503604"],"award-info":[{"award-number":["2023ZD0503604"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03293-y","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:56:43Z","timestamp":1784224603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association between the combined cholesterol, high-density lipoprotein, glucose index and frailty index and new-onset cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0\u20133: evidence from CHARLS"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhonghua","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yameng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisaierjiang","family":"Kadier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"25","key":"3293_CR1","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","volume":"80","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol. 2022;80(25):2361\u201371. https:\/\/doi.org\/10.1016\/j.jacc.2022.11.005.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"3293_CR2","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","volume":"82","author":"GA Mensah","year":"1990","unstructured":"Mensah GA, Fuster V, Murray CJL, Roth GA, Mensah GA, Abate YH, et al. Global burden of cardiovascular diseases and risks, 1990-2022. J Am Coll Cardiol. 1990;82(25):2350\u2013473. https:\/\/doi.org\/10.1016\/j.jacc.2023.11.007.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3293_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/inm3.70000","volume":"1","author":"Z Wang","year":"2025","unstructured":"Wang Z, Chen S, Xu S, Weng J. Risk factors for cardiovascular and metabolic disease: integrating traditional and novel paradigms. iNew Medicine. 2025;1(1):e70000. https:\/\/doi.org\/10.1002\/inm3.70000.","journal-title":"iNew Medicine"},{"issue":"12","key":"3293_CR4","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1111\/dom.14829","volume":"24","author":"T Kadowaki","year":"2022","unstructured":"Kadowaki T, Maegawa H, Watada H, Yabe D, Node K, Murohara T, et al. Interconnection between cardiovascular, renal and metabolic disorders: a narrative review with a focus on Japan. Diabetes Obes Metab. 2022;24(12):2283\u201396. https:\/\/doi.org\/10.1111\/dom.14829.","journal-title":"Diabetes Obes Metab"},{"issue":"Suppl 1","key":"3293_CR5","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.5551\/jat.21_sup.1-s31","volume":"21","author":"S Suh","year":"2014","unstructured":"Suh S, Lee M-K. Metabolic syndrome and cardiovascular diseases in Korea. J Atheroscler Thromb. 2014;21(Suppl 1):S31-35. https:\/\/doi.org\/10.5551\/jat.21_sup.1-s31.","journal-title":"J Atheroscler Thromb"},{"issue":"1","key":"3293_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12933-023-01937-x","volume":"22","author":"M Marassi","year":"2023","unstructured":"Marassi M, Fadini GP. The cardio-renal-metabolic connection: a review of the evidence. Cardiovasc Diabetol. 2023;22(1):195. https:\/\/doi.org\/10.1186\/s12933-023-01937-x.","journal-title":"Cardiovasc Diabetol"},{"issue":"21","key":"3293_CR7","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","volume":"331","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of Cardiovascular-Kidney-Metabolic syndrome stages in US adults, 2011\u20132020. JAMA. 2024;331(21):1858\u201360. https:\/\/doi.org\/10.1001\/jama.2024.6892.","journal-title":"JAMA"},{"issue":"24","key":"3293_CR8","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1161\/cir.0000000000001191","volume":"148","author":"SS Khan","year":"2023","unstructured":"Khan SS, Coresh J, Pencina MJ, Ndumele CE, Rangaswami J, Chow SL, et al. Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating Cardiovascular-Kidney-Metabolic health: a scientific statement from the American Heart Association. Circulation. 2023;148(24):1982\u20132004. https:\/\/doi.org\/10.1161\/cir.0000000000001191.","journal-title":"Circulation"},{"issue":"1","key":"3293_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/inm3.70001","volume":"1","author":"Z Li","year":"2025","unstructured":"Li Z, Dai Y, Ge J. Panvascular disease: opportunities and challenges. iNew Med. 2025;1(1):e70001. https:\/\/doi.org\/10.1002\/inm3.70001.","journal-title":"iNew Med"},{"issue":"20","key":"3293_CR10","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular-Kidney-Metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023;148(20):1606\u201335. https:\/\/doi.org\/10.1161\/CIR.0000000000001184.","journal-title":"Circulation"},{"issue":"20","key":"3293_CR11","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, et al. A synopsis of the evidence for the science and clinical management of Cardiovascular-Kidney-Metabolic (CKM) syndrome: a scientific statement from the American Heart Association. Circulation. 2023;148(20):1636\u201364. https:\/\/doi.org\/10.1161\/CIR.0000000000001186.","journal-title":"Circulation"},{"issue":"1","key":"3293_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12933-025-02917-z","volume":"24","author":"YS Lyu","year":"2025","unstructured":"Lyu YS, Lee H, Kim KS, Hong S, Park CY. Weight-independent amelioration of adipokine profile by enavogliflozin, a selective SGLT2 inhibitor, in patients with type 2 diabetes. Cardiovasc Diabetol. 2025;24(1):355. https:\/\/doi.org\/10.1186\/s12933-025-02917-z.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"3293_CR13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cmet.2011.07.015","volume":"14","author":"KE Bornfeldt","year":"2011","unstructured":"Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 2011;14(5):575\u201385. https:\/\/doi.org\/10.1016\/j.cmet.2011.07.015.","journal-title":"Cell Metab"},{"issue":"1","key":"3293_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02511-9","volume":"23","author":"C Duan","year":"2024","unstructured":"Duan C, Lyu M, Shi J, Shou X, Zhao L, Hu Y. Associations of baseline and changes in the triglyceride glucose-weight adjusted waist index and cardiovascular disease risk: evidence from middle-aged and older individuals. Cardiovasc Diabetol. 2024;23(1):415. https:\/\/doi.org\/10.1186\/s12933-024-02511-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3293_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02088-9","volume":"22","author":"CS Sheng","year":"2023","unstructured":"Sheng CS, Wang H, Liu Y, Li Y, Hou T, Qiu M, et al. Long-term effects of blood pressure 130-139\/80-89 mmHg on all-cause and cardiovascular mortality among Chinese adults with different glucose metabolism. Cardiovasc Diabetol. 2023;22(1):353. https:\/\/doi.org\/10.1186\/s12933-023-02088-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3293_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12933-025-03051-6","volume":"25","author":"G Huo","year":"2025","unstructured":"Huo G, Chen Y, Tang Y, Zhou D. Association between combined atherogenic and frailty index and cardiovascular events: evidence from the CHARLS cohort. Cardiovasc Diabetol. 2025;25(1):33. https:\/\/doi.org\/10.1186\/s12933-025-03051-6.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3293_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-02033-8","volume":"18","author":"Y Wang","year":"2025","unstructured":"Wang Y, Yu Q. METS-IR predicts new-onset stroke in older adults with stages 0-3 cardiovascular-kidney-metabolic syndrome: a prospective, multicohort, clinical study with statistical and machine learning. Diabetol Metab Syndr. 2025;18(1):6. https:\/\/doi.org\/10.1186\/s13098-025-02033-8.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"3293_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12933-025-02589-9","volume":"24","author":"G Zheng","year":"2025","unstructured":"Zheng G, Jin J, Wang F, Zheng Q, Shao J, Yao J, et al. Association between atherogenic index of plasma and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):22. https:\/\/doi.org\/10.1186\/s12933-025-02589-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3293_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12933-025-02842-1","volume":"24","author":"K Liu","year":"2025","unstructured":"Liu K, Hu J, Huang Y, He D, Zhang J. Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with cardiovascular-kidney-metabolic (CKM) syndrome stages 0\u20133: a prospective cohort study of 282,920 participants in the UK Biobank. Cardiovasc Diabetol. 2025;24(1):277. https:\/\/doi.org\/10.1186\/s12933-025-02842-1.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3293_CR20","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12933-025-02932-0","volume":"24","author":"H Wu","year":"2025","unstructured":"Wu H, Zhou Y, Lai X, Ma B, Ding L, Zhu X, et al. Association between metabolic score for insulin resistance and future stroke risk in patients with cardiovascular-kidney-metabolic syndrome stages 0\u20133: a longitudinal analysis based on CHARLS. Cardiovasc Diabetol. 2025;24(1):379. https:\/\/doi.org\/10.1186\/s12933-025-02932-0.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"3293_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/jdi.14343","volume":"16","author":"A Mansoori","year":"2025","unstructured":"Mansoori A, Nosrati M, Dorchin M, Mohammadyari F, Derakhshan-Nezhad E, Ferns G, et al. A novel index for diagnosis of type 2 diabetes mellitus: cholesterol, high density lipoprotein, and glucose (CHG) index. J Diabetes Investig. 2025;16(2):309\u201314. https:\/\/doi.org\/10.1111\/jdi.14343.","journal-title":"J Diabetes Investig"},{"key":"3293_CR22","doi-asserted-by":"publisher","DOI":"10.1177\/03000605251375557","author":"Z Zhang","year":"2009","unstructured":"Zhang Z, Chen M, Cai D, Fan M, Wang Y. Association between the cholesterol, high-density lipoprotein, and glucose index and type 2 diabetes mellitus prevalence in US adults: a cross-sectional study based on National Health and Nutrition Examination Survey 2009\u20132018. J Int Med Res. 2009. https:\/\/doi.org\/10.1177\/03000605251375557.","journal-title":"J Int Med Res"},{"issue":"1","key":"3293_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.mcna.2022.04.006","volume":"107","author":"CI Cohen","year":"2023","unstructured":"Cohen CI, Benyaminov R, Rahman M, Ngu D, Reinhardt M. Frailty: a multidimensional biopsychosocial syndrome. Med Clin North Am. 2023;107(1):183\u201397. https:\/\/doi.org\/10.1016\/j.mcna.2022.04.006.","journal-title":"Med Clin North Am"},{"issue":"1","key":"3293_CR24","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12933-025-02880-9","volume":"24","author":"YC Zhao","year":"2025","unstructured":"Zhao YC, Wu SQ, Li JK, Sun ZH, Zhang BK, Fu R, et al. Predictive value of the combined triglyceride-glucose and frailty index for cardiovascular disease and stroke in two prospective cohorts. Cardiovasc Diabetol. 2025;24(1):318. https:\/\/doi.org\/10.1186\/s12933-025-02880-9.","journal-title":"Cardiovasc Diabetol"},{"key":"3293_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-026-03213-0","author":"H Fan","year":"2026","unstructured":"Fan H, Jiang G, Cheng J, Chen H. Predictive value of the combined cholesterol, high-density lipoprotein, glucose and frailty indices for cardiometabolic multimorbidity incidence: evidence from a national prospective cohort study. Cardiovasc Diabetol. 2026. https:\/\/doi.org\/10.1186\/s12933-026-03213-0.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3293_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the china health and retirement longitudinal study (CHARLS). Int J Epidemiol. 2014;43(1):61\u20138. https:\/\/doi.org\/10.1093\/ije\/dys203.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"3293_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02921-3","volume":"24","author":"M Chen","year":"2025","unstructured":"Chen M, Guo J, Shangguan Y, Sun Z, He X, Tu Q, et al. Association of the triglyceride-glucose index combined with a body shape index with all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome stage 0-3: findings from two prospective cohorts. Cardiovasc Diabetol. 2025;24(1):366. https:\/\/doi.org\/10.1186\/s12933-025-02921-3.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"3293_CR28","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1093\/aje\/kwz170","volume":"188","author":"X Chen","year":"2019","unstructured":"Chen X, Crimmins E, Hu P, Kim JK, Meng Q, Strauss J, et al. Venous blood-based biomarkers in the China health and retirement longitudinal study: rationale, design, and results from the 2015 wave. Am J Epidemiol. 2019;188(11):1871\u20137. https:\/\/doi.org\/10.1093\/aje\/kwz170.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"3293_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2318-8-24","volume":"8","author":"SD Searle","year":"2008","unstructured":"Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatr. 2008;8(1):24. https:\/\/doi.org\/10.1186\/1471-2318-8-24.","journal-title":"BMC Geriatr"},{"issue":"12","key":"3293_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnha.2024.100398","volume":"28","author":"L Sun","year":"2024","unstructured":"Sun L, Deng G, Lu X, Xie X, Kang L, Sun T, et al. The association between continuing work after retirement and the incidence of frailty: evidence from the China health and retirement longitudinal study. J Nutr Health Aging. 2024;28(12):100398. https:\/\/doi.org\/10.1016\/j.jnha.2024.100398.","journal-title":"J Nutr Health Aging"},{"key":"3293_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-026-03235-8","author":"X Feng","year":"2026","unstructured":"Feng X, Deng B, Pan Y, Liu K, Lei W, Tang X, et al. Associations of cumulative exposure and dynamic trajectories of the combined atherogenic and frailty index with incident cardiometabolic multimorbidity: a longitudinal analysis based on the China health and retirement longitudinal study (CHARLS). Cardiovasc Diabetol. 2026. https:\/\/doi.org\/10.1186\/s12933-026-03235-8.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3293_CR32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12933-025-02675-y","volume":"24","author":"D Mo","year":"2025","unstructured":"Mo D, Zhang P, Zhang M, Dai H, Guan J. Cholesterol, high-density lipoprotein, and glucose index versus triglyceride\u2013glucose index in predicting cardiovascular disease risk: a cohort study. Cardiovasc Diabetol. 2025;24(1):116. https:\/\/doi.org\/10.1186\/s12933-025-02675-y.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"3293_CR33","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/jdi.70086","volume":"16","author":"M \u00c7atak","year":"2025","unstructured":"\u00c7atak M, Konuk \u015eG, Hepsen S. The cholesterol-HDL-glucose (CHG) index and traditional adiposity markers in predicting diabetic retinopathy and nephropathy. J Diabetes Investig. 2025;16(8):1487\u201394. https:\/\/doi.org\/10.1111\/jdi.70086.","journal-title":"J Diabetes Investig"},{"issue":"12","key":"3293_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052036","volume":"7","author":"KB Gast","year":"2012","unstructured":"Gast KB, Tjeerdema N, Stijnen T, Smit JW, Dekkers OM. Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLoS ONE. 2012;7(12):e52036. https:\/\/doi.org\/10.1371\/journal.pone.0052036.","journal-title":"PLoS ONE"},{"issue":"1","key":"3293_CR35","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12933-025-02860-z","volume":"24","author":"H Zhang","year":"2025","unstructured":"Zhang H, Huang S, Fang Y, Zhang H, Yang W, Yu M. Insulin resistance assessed by estimated glucose disposal rate predicts cardiovascular disease in stages 0\u20133 of cardiovascular-kidney-metabolic syndrome: a UK biobank cohort study. Cardiovasc Diabetol. 2025;24(1):360. https:\/\/doi.org\/10.1186\/s12933-025-02860-z.","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"3293_CR36","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/eurheartj\/ehad885","volume":"45","author":"D He","year":"2024","unstructured":"He D, Wang Z, Li J, Yu K, He Y, He X, et al. Changes in frailty and incident cardiovascular disease in three prospective cohorts. Eur Heart J. 2024;45(12):1058\u201368. https:\/\/doi.org\/10.1093\/eurheartj\/ehad885.","journal-title":"Eur Heart J"},{"key":"3293_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1592565","volume":"16","author":"Y Song","year":"2025","unstructured":"Song Y, Liu J, Wang S, Shi H, Han L. Association between frailty trajectories and stroke incidence among Chinese older adults: evidence from CHARLS 2011\u20132015. Front Neurol. 2025;16:1592565. https:\/\/doi.org\/10.3389\/fneur.2025.1592565.","journal-title":"Front Neurol"},{"issue":"2","key":"3293_CR38","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/ehf2.14595","volume":"11","author":"W Li","year":"2024","unstructured":"Li W, Wang Z, Hua C, Zhang H, Liu X, Zheng S, et al. Body mass index, frailty, and outcomes in heart failure with preserved ejection fraction. ESC Heart Fail. 2024;11(2):709\u201318. https:\/\/doi.org\/10.1002\/ehf2.14595.","journal-title":"ESC Heart Fail"},{"issue":"1","key":"3293_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12933-025-03067-y","volume":"25","author":"H Lai","year":"2026","unstructured":"Lai H, Deng C, Liao C, Tian R, Liu K, Luo Z, et al. Joint assessment of insulin resistance surrogate indices and basal metabolic rate for primary prevention of cardiometabolic multimorbidity: evidence from the China Health and Retirement Longitudinal Study (2011\u20132020). Cardiovasc Diabetol. 2026;25(1):37. https:\/\/doi.org\/10.1186\/s12933-025-03067-y.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"3293_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/inm3.70007","volume":"2","author":"Z Wang","year":"2026","unstructured":"Wang Z, Su M, Li Y, Li Y, Chen S, Peng T, et al. Metabolic signatures and diagnostic prediction models for coronary artery disease and type 2 diabetes mellitus: insights from an exploratory study. iNew Med. 2026;2(2):e70007. https:\/\/doi.org\/10.1002\/inm3.70007.","journal-title":"iNew Med"},{"key":"3293_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210308","author":"YV Markina","year":"2023","unstructured":"Markina YV, Kirichenko TV, Tolstik TV, Bogatyreva AI, Zotova U, Cherednichenko VR, et al. Target and cell therapy for atherosclerosis and CVD. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241210308.","journal-title":"Int J Mol Sci"},{"key":"3293_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154766","volume":"119","author":"MA Hill","year":"2021","unstructured":"Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766. https:\/\/doi.org\/10.1016\/j.metabol.2021.154766.","journal-title":"Metabolism"},{"issue":"n\/a","key":"3293_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/inm3.70028","volume":"n\/a","author":"PJ Little","year":"2026","unstructured":"Little PJ, Offermanns S, Cho H, Liu Z, Yang P, Su Q, et al. Insulin resistance: an update on biochemical and pathophysiological mechanisms and impact on various diseases. iNew Med. 2026;n\/a(n\/a):e70028. https:\/\/doi.org\/10.1002\/inm3.70028.","journal-title":"iNew Med"},{"issue":"9","key":"3293_CR44","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.5551\/jat.ED240","volume":"30","author":"T Hirata","year":"2023","unstructured":"Hirata T. Impact of frailty on cardiovascular disease in older adults. J Atheroscler Thromb. 2023;30(9):1104\u20135. https:\/\/doi.org\/10.5551\/jat.ED240.","journal-title":"J Atheroscler Thromb"},{"key":"3293_CR45","doi-asserted-by":"publisher","first-page":"e05","DOI":"10.15420\/icr.2020.18","volume":"16","author":"K Chung","year":"2021","unstructured":"Chung K, Wilkinson C, Veerasamy M, Kunadian V. Frailty scores and their utility in older patients with cardiovascular disease. Interv Cardiol. 2021;16:e05. https:\/\/doi.org\/10.15420\/icr.2020.18.","journal-title":"Interv Cardiol"},{"issue":"1","key":"3293_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/inm3.70026","volume":"2","author":"H Liang","year":"2026","unstructured":"Liang H, Wang Y, Zhang Y, Tang X. A senolytic strategy for metabolic health: why the endothelium matters. iNew Med. 2026;2(1):e70026. https:\/\/doi.org\/10.1002\/inm3.70026.","journal-title":"iNew Med"},{"issue":"2","key":"3293_CR47","doi-asserted-by":"publisher","DOI":"10.1111\/acel.70372","volume":"25","author":"M Milan","year":"2026","unstructured":"Milan M, Troyano-Rodriguez E, Ihuoma J, Negri S, Rudraboina R, Kosmider A, et al. Fasting as medicine: mitochondrial and endothelial rejuvenation in vascular aging. Aging Cell. 2026;25(2):e70372. https:\/\/doi.org\/10.1111\/acel.70372.","journal-title":"Aging Cell"},{"issue":"9","key":"3293_CR48","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","volume":"15","author":"L Ferrucci","year":"2018","unstructured":"Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15(9):505\u201322. https:\/\/doi.org\/10.1038\/s41569-018-0064-2.","journal-title":"Nat Rev Cardiol"},{"key":"3293_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arr.2016.08.006","volume":"31","author":"P Soysal","year":"2016","unstructured":"Soysal P, Stubbs B, Lucato P, Luchini C, Solmi M, Peluso R, et al. Inflammation and frailty in the elderly: a systematic review and meta-analysis. Ageing Res Rev. 2016;31:1\u20138. https:\/\/doi.org\/10.1016\/j.arr.2016.08.006.","journal-title":"Ageing Res Rev"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03293-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03293-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03293-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:04:25Z","timestamp":1791907465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03293-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3293"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03293-y","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"26 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Biomedical Ethics Review Committee of Peking University (Approval No. IRB00001052-11015). Written informed consent was obtained from all participants, and the study was conducted in strict adherence to the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"303"}}